1887
Articles Open Access
Like 0
This item has no PDF Download

Abstract

Laboratory tests have confirmed that a patient who died last week in a hospital in, Lanarkshire, Scotland, was infected with a Glycopeptide Intermediate Resistant Staphylococcus aureus (GISA) (1). GISA has increased resistance to first line antibiotics used for treating infections caused by methicillin resistant Staphylococcus aureus (MRSA), namely, vancomycin and teicoplanin (2). This is the second report of an infection with this organism for Scotland, and possibly the first report in the United Kingdom of an associated death. (3).

Loading

Article metrics loading...

/content/10.2807/esw.06.51.01989-en
2002-12-19
2017-11-20
http://instance.metastore.ingenta.com/content/10.2807/esw.06.51.01989-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurvweeklyarchive/6/51/art01989-en.htm?itemId=/content/10.2807/esw.06.51.01989-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error